… coronavirus disease, named COVID-19 by the World Health Organization (WHO 2). The
causative agent of this infection is the severe acute respiratory syndrome coronavirus … COVID-19 …

… COVID-19 treatment. At present remdesivir is approved by the Italian Medicines Agency (AIFA)
for COVID-19 … of the incomplete evidence in treatment approach of COVID-19, we suggest …

… syndrome coronavirus 2 (SARS-CoV-2) also named COVID-19. The … The COVID-19 disease
is distributed by inhalation via … trials, and treatment strategies for COVID-19 is updating. …

… requires complex treatment to reduce viral … treatment of favipiravir, steroid, and heparin
for COVID-19. This study aimed to evaluate the effect of cocktail therapy for severe COVID-19…

… ies regarding diagnosing COVID-19. RESULTS: Here … COVID-19 like lung ultrasound.
CONCLUSIONS: Chinese Clinical Guidance for COVID-19 Pneumonia Diagnosis and Treatment (…

… and/or support treatment of the symptomatology associated with COVID-19 (Table 1). The
therapy can be tailored to the patient’s needs or given all together as a single formulation. …

… Although drug repurposing has some limitations, repositioning clinical trials may represent
an attractive strategy because they facilitate the discovery of new classes of medicines; they …

… a safe and immunologically effective COVID-19 vaccine strategy, how to define successful
… for the design of COVID-19 vaccine strategies and analyses the current COVID-19 vaccine …

… The complexity of the clinic and the ambiguity of the pathogenic mechanism significantly
increase the difficulty of evaluation and treatment strategy selection for COVID-19 patients. …

… Therefore, the NLRP3 inflammasome can be a potential target for the treatment of COVID-19.
Hence, this review first introduces the canonical NLRP3 inflammasome activation pathway. …